Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The Sun, Diabetes UK, Citeline News & Insights and The Times. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 2h ago.
Quick answers
Why is "Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- Drug that delays type 1 diabetes approved for NHS The Telegraph · 6h ago
- Drug that delays onset of type 1 diabetes approved in England and Wales The Guardian · 6h ago
- Breakthrough in type 1 diabetes as drug offered on NHS delays start of disease The Sun · 6h ago
- Teplizumab, the first treatment to slow type 1 diabetes, approved for use on the NHS Diabetes UK · 6h ago
- England Leads Europe In Reimbursing Sanofi’s Type 1 Diabetes Disease-Modifying Therapy Tzield Citeline News & Insights · 6h ago
- Type 1 diabetes drug will delay onset by three years The Times · 6h ago
- Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS BBC · 6h ago
Topics
Related trends
Thousands of men with prostate cancer will now be offered high-powered radiotherapy on the NHS
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
The Diet That May Lower Bad Cholesterol 'As Much As A Statin'
Medical reports highlight a four-pillar diet regimen as a potential nutritional approach to managing cholesterol levels.
Five myths about prostate cancer, according to an oncologist
Prostate cancer awareness surges as experts debunk myths and highlight overlooked symptoms during Men’s Health Month
'I've never been this good'
A lupus treatment borrowed from cancer therapy is putting patients into remission—with one calling it life-changing.
Meningitis B vaccine to be offered to thousands of young people in July
UK launches emergency MenB vaccine rollout for 1 million young people amid largest outbreak in years